Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL

The predictors of hepatitis B virus (HBV) relapse and HBsAg loss after cessation of nucleos(t)ide analogues (NA) in HBeAg-negative patients with end-of-treatment HBsAg ≤ 200 IU/mL remains unclear. The study recruited 119 chronic hepatitis B (CHB) patients who achieved end-of-treatment HBsAg ≤ 200 IU...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Chih-Chien, Hung, Chao-Hung, Hu, Tsung-Hui, Lu, Sheng-Nan, Wang, Jing-Hung, Lee, Chung-Mo, Chen, Chien-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431802/
https://www.ncbi.nlm.nih.gov/pubmed/28500322
http://dx.doi.org/10.1038/s41598-017-02010-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431802/
https://www.ncbi.nlm.nih.gov/pubmed/28500322
http://dx.doi.org/10.1038/s41598-017-02010-w

Ejemplares similares